Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones

被引:66
作者
Aguilar, Fernando
Crebelli, Riccardo
Di Domenico, Alessandro
Dusemund, Birgit
Frutos, Maria Jose
Galtier, Pierre
Gott, David
Gundert-Remy, Ursula
lambre, Claude
Leblanc, Jean-Charles
Lindtner, Oliver
Moldeus, Peter
Mortensen, Alicja
Mosesso, Pasquale
Parent-Massin, Dominique
Oskarsson, Agneta
Stankovic, Ivan
Waalkens-Berendsen, Ine
Woutersen, Rudolf Antonius
Wright, Matthew
Younes, Maged
机构
关键词
isoflavones; phytoestrogens; food supplements; mammary gland; uterus; thyroid; systematic review;
D O I
10.2903/j.efsa.2015.4246
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The EFSA ANS Panel was asked to deliver a scientific opinion on the possible association between the intake of isoflavones from food supplements and harmful effects on mammary gland, uterus and thyroid in peri- and post-menopausal women. Isoflavones are naturally occurring substances which can be found in, among other sources, soy, red clover and kudzu root. The main isoflavones are genistein, daidzein, glycitein, formononetin, biochanin A and puerarin. Their chemical structures are related to 17 beta-oestradiol and they possess oestrogenic properties. Furthermore, isoflavones may interact with the synthesis of thyroid hormone. Food supplements targeted at peri-and postmenopausal women typically provide a daily dose of isoflavones in the range of 35-150 mg/day. A systematic review was performed to investigate whether an association could be found between intake of isoflavones from food supplements and adverse effects on the three target organs in peri-and post-menopausal women. The human data did not support the hypothesis of an increased risk of breast cancer from observational studies nor of an effect on mammographic density nor on proliferation marker Ki-67 expression in interventional studies. No effect was found on endometrial thickness and histopathological changes in the uterus up to 30 months of supplementation with 150 mg/day of soy isoflavones. After 60 months some non-malignant histopathological changes were reported. Thyroid hormones levels were not changed following intake of isoflavones from food supplements. The background exposure from the diet in the general European population was estimated to be lower than 1 mg/day, whereas in consumers of soy-based foods it could be higher. The Panel concluded that it was not possible to derive a single health-based guidance value for the different preparations in post-menopausal women. However the doses used in the intervention studies and their duration could serve as guidance for the intake of food supplements. (C) European Food Safety Authority, 2015
引用
收藏
页数:342
相关论文
共 310 条
  • [1] Infantile leukemia and soybeans - a hypothesis
    Abe, T
    [J]. LEUKEMIA, 1999, 13 (03) : 317 - 320
  • [2] Efficacy of red clover isoflavones in the menopausal rabbit model
    Adaikan, P. Ganesan
    Srilatha, B.
    Wheat, Amanda J.
    [J]. FERTILITY AND STERILITY, 2009, 92 (06) : 2008 - 2013
  • [3] AFFSA (Agence francaise de securite sanitaire des aliments), 2005, SEC BEN PHYT APP AL
  • [4] Scientific Opinion on the safety of a 'fermented black bean extract (Touchi extract)' as a Novel Food ingredient
    Agostini, Carlo Virgilio
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Heinonen, Marina
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Sanz, Yolanda
    Salminen, Seppo
    Strain, John J.
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    [J]. EFSA JOURNAL, 2011, 9 (05)
  • [5] Scientific Opinion on the substantiation of health claims related to soy protein and contribution to the maintenance or achievement of a normal body weight (ID 598), maintenance of normal blood cholesterol concentrations (ID 556) and protection of DNA, proteins and lipids from oxidative damage (ID 435) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    [J]. EFSA JOURNAL, 2010, 8 (10)
  • [6] Scientific Opinion on the substantiation of health claims related to soy isoflavones and maintenance of bone mineral density (ID 1655) and reduction of vasomotor symptoms associated with menopause (ID 1654, 1704, 2140, 3093, 3154, 3590) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    [J]. EFSA JOURNAL, 2012, 10 (08)
  • [7] AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
  • [8] Alekel DL, 2015, MENOPAUSE, V22, P185, DOI [10.1097/gme.0000000000000280, 10.1097/GME.0000000000000280]
  • [9] Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized balb/c mice
    Allred, CD
    Twaddle, NC
    Allred, KF
    Goeppinger, TS
    Churchwell, MI
    Ju, YH
    Helferich, WG
    Doerge, DR
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, 53 (22) : 8542 - 8550
  • [10] Allred CD, 2001, CANCER RES, V61, P5045